Advertisement

Neuromuscular Respiratory Failure

  • Margaret F. Guill
  • Thomas P. Shanley
Chapter

Keywords

Spinal Muscular Atrophy Functional Residual Capacity Duchenne Muscular Dystrophy Demyelinating Polyneuropathy Maximal Inspiratory Pressure 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Miske LJ, Hickey EM, Kolb SJ, Weiner DJ, Panitch HB. Use of the mechanical in-exsufflator in pediatric patients with neuromuscular disease and impaired cough. Chest 2004;125:1406–1412.PubMedCrossRefGoogle Scholar
  2. 2.
    Bach JR, Niranjan V, Weaver B. Spinal muscular atrophy type 1—a noninvasive respiratory management approach. Chest 2000;117: 1100–1105.PubMedCrossRefGoogle Scholar
  3. 3.
    Bach JR, Baird JS, Plosky D, Navado J, Weaver B. Spinal muscular atrophy type 1: management and outcomes. Pediatr Pulmonol 2002; 34:16–22.PubMedCrossRefGoogle Scholar
  4. 4.
    Gomez-Merino E. Duchenne muscular dystrophy: prolongation of life by noninvasive ventilation and mechanically assisted coughing. Am J Phys Med Rehabil 2002;81:411–415.PubMedCrossRefGoogle Scholar
  5. 5.
    Hardart MKM, Burns JP, Truog RD. Respiratory support in spinal muscular atrophy type 1: a survey of physician practices and attitudes. Pediatrics 2002;110:e24.PubMedCrossRefGoogle Scholar
  6. 6.
    Murray JF. Respiratory muscles. In: The Normal Lung, 2nd ed. Murray JF, ed. Philadelphia: WB Saunders; 1986:121–138.Google Scholar
  7. 7.
    Derenne JP, Macklem PT, Roussos C: The respiratory muscles: mechanics, control and pathophysiology. Parts I, II and III. Am Rev Respir Dis 1978;118–133, 373–390, 581–601.Google Scholar
  8. 8.
    DeTroyer A, Loring SH. Action of respiratory muscles. In: Mecklem PT, Mead J, eds. Handbook of Physiology: The Respiratory System—Mechanics of Breathing, vol III. Bethesda, MD: American Physiological Society; 1986:453.Google Scholar
  9. 9.
    Roussos C, Macklem PT. The respiratory muscles. N Engl J Med 1982;307:786–792.PubMedCrossRefGoogle Scholar
  10. 10.
    Agostini E, Mead J. Statics of the respiratory system. In: Fenn WO, Rahn H, eds. Handbook of Physiology, vol 1. Washington, DC: American Physiological Society, 1964:401.Google Scholar
  11. 11.
    Altose MD. Pulmonary mechanics. In: Fisherman AP, ed. Pulmonary Disease and Disorders, vol 1, 2nd ed. New York: McGraw-Hill; 1988:171–184.Google Scholar
  12. 12.
    D’Angelo E. Statics of the chest wall. In: Roussos C, Macklem PT, eds. Thorax, part A. New York: Dekker; 1985:259–295.Google Scholar
  13. 13.
    Agostini E. Mechanics of the pleural pressure space. In: Macklem PT, Mead J, eds. Mechanics of Breathing, part 2, Handbook of Physiology, sec 3: The Respiratory System, vol 32. Bethesda, MD: American Physiological Society; 1964:531–559.Google Scholar
  14. 14.
    Rosen CL. Maturation of breathing during sleep. In: Louglin G, Carroll J, Marcus C, eds. Sleep and Breathing in Children, 1st ed. New York: Dekker; 2000:181–205.Google Scholar
  15. 15.
    Allen J, Gripp K. Development of thoracic cage. In: Chernick-Mellins, eds. Basic Mechanisms of Pediatric Respiratory Disease, 2nd ed. London: BC Decker; 2002:124–138.Google Scholar
  16. 16.
    Papastomelos C, Panitch H, England S, Allen J. Developmental changes in chest wall compliance in infancy and early childhood. J Appl Physiol 1995;78:179–184.Google Scholar
  17. 17.
    Gerhardt T, Bancalari E. Chest wall compliance in full term and premature infants. Acta Paediatr Scand 1980;69:359–364.PubMedCrossRefGoogle Scholar
  18. 18.
    Openshaw P, Edwards S, Helms P. Changes in rib cage geometry during childhood. Thorax 1984;39:624–627.PubMedCrossRefGoogle Scholar
  19. 19.
    Keens TG, Bryan AC, Levison H, Ianuzzo CD. Developmental pattern of muscle fiber types in human ventilatory muscles. J Appl Physiol Respir Environ Exerc Physiol 1978;44:909–913.Google Scholar
  20. 20.
    Gaultier C, Praud JP, Canet E, Delaperche MF, D’Allest AM. Paradoxical inward rib cage motion during rapid eye movement sleep in infants and young children. J Dev Physiol 1987;9:391– 397.PubMedGoogle Scholar
  21. 21.
    Gaultier C. Cardiorespiratory adaptation during sleep in infants and children. Pediatr Pulmonol 1995;19:105–117.PubMedCrossRefGoogle Scholar
  22. 22.
    England S, Gaultier C, Bryan A. Chest wall mechanics in the newborn. In: Roussos C, ed. The Thorax: Lung Biology in Health and Disease, 2nd ed. New York: Dekker, 1995:1541–1556.Google Scholar
  23. 23.
    Kosch PC, Stark AR. Dynamic maintenance of end-expiratory lung volume in full term infants. J Appl Physiol 1984;57:1126– 1133.PubMedGoogle Scholar
  24. 24.
    Kosch PC, Hutchison AA, Wozniak JA, et al. Posterior cricoarytenoid and diaphragm activities during tidal breathing in neonates. J Appl Physiol 1988;64:1968–1978.PubMedGoogle Scholar
  25. 25.
    Collin AA, Wohl ME, Mead J, Ratjen FA, Glass G, Stark AR. Transition from dynamically maintained to relaxed end-expiratory volume in human infants. J Appl Physiol 1989;67:2107–2111.Google Scholar
  26. 26.
    Stark AR, Cohlan BA, Waggener TB, Frantz ID III, Kosch PC. Regulation of end-expiratory lung volume during sleep in premature infants. J Appl Physiol 1987;62:1117–1123.PubMedCrossRefGoogle Scholar
  27. 27.
    Tabachnik E, Muller NL, Bryan AC, Levsion H. Changes in ventilation and chest wall mechanics during sleep in normal adolescents. J Appl Physiol 1981;51:557–564.PubMedGoogle Scholar
  28. 28.
    Dimitoru G, Greenough A, Dyke H, Rafferty GF. Maximal airway pressures during crying in healthy preterm and term neonates. Early Hum Dev 2000;57:149–156.CrossRefGoogle Scholar
  29. 29.
    Gaultier C, Zinman R. Maximal static pressures in healthy children. Respir Physiol 1983;51:45–61.PubMedCrossRefGoogle Scholar
  30. 30.
    Shardonofsky FR, Perez-Chada D, Carmuega E, Milic-Emili J. Airway pressures during crying in healthy infants. Pediatr Pulmonol 1989; 6:14–18.PubMedCrossRefGoogle Scholar
  31. 31.
    Wagener JS, Hibbert ME, Landau LI. Maximal respiratory pressures in children. Am Rev Respir Dis 1984;129:873–875.PubMedGoogle Scholar
  32. 32.
    Rochester DF, Arora NS. Respiratory muscle failure. Med Clin North Am 1983;67:573–597.PubMedGoogle Scholar
  33. 33.
    Allen J. Respiratory function in children with neuromuscular disease. Monaldi Arch Chest Dis 1996;51:230–235.PubMedGoogle Scholar
  34. 34.
    MacDuff A, Grand IS. Critical care management of neuromuscular disease, including long term ventilation. Curr Opin Crit Care 2003; 9:106–112.PubMedCrossRefGoogle Scholar
  35. 35.
    Padman R. Respiratory management of pediatric patients with spinal cord injuries: retrospective review of the duPont experience. Neurorehabil Neural Repair 2003;17:32–36.PubMedCrossRefGoogle Scholar
  36. 36.
    Lorin S, Nierman DM. Critical illness neuromuscular abnormalities. Crit Care Clin 2002;18:553–568.PubMedCrossRefGoogle Scholar
  37. 37.
    Greenstein P. Tick paralysis. Med Clin North Am 2002;86:441– 446.PubMedCrossRefGoogle Scholar
  38. 38.
    Gordon BM, Giza CC. Tick paralysis presenting in an urban environment. Pediatr Neurol 2004;30:122–124.PubMedCrossRefGoogle Scholar
  39. 39.
    Felz MW, Smith CD, Swift TR. Brief report: a six year old girl with tick paralysis. N Engl J Med 2000;342:90–94.PubMedCrossRefGoogle Scholar
  40. 40.
    Li Z, Turner RP. Pediatric tick paralysis: discussion of two cases and literature review. Pediatr Neurol 2004;31:304–307.PubMedCrossRefGoogle Scholar
  41. 41.
    Armada M, Love S, Barrett E, Monroe J, Peery D, Sobel J. Foodborne botulism in a six month old infant caused by home canned baby food. Ann Emerg Med 2003;42:226–229.PubMedCrossRefGoogle Scholar
  42. 42.
    Marks, JD. Medical aspects of biologic toxins. Anesthesiol Clin North Am 2004;22:509–532.CrossRefGoogle Scholar
  43. 43.
    American Academy of Pediatrics. Botulism. In: Pickering LK, ed. Pediatric Red Book: 2003 Report of the Committee on Infectious Diseases, 26th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2003:243–246.Google Scholar
  44. 44.
    Cox N, Hinkle R. Infant botulism. Am Fam Physician 2002;65:1388– 1392.PubMedGoogle Scholar
  45. 45.
    Fox CK, Keet CA, Strober JB. Recent advances in infant botulism. Pediatr Neurol 2005;32:149–154.PubMedCrossRefGoogle Scholar
  46. 46.
    St John R, Finlay B, Blau C. Bioterrorism in Canada: an economic assessment of preventive and postattack exposure. Can J Infect Dis 2001;12:275–284.PubMedGoogle Scholar
  47. 47.
    Leissner KB, Holzman RS, McCann ME. Bioterrorism in children: unique concerns with infection control and vaccination. Anesthesiol Clin North Am 2004;22(3):563–577.Google Scholar
  48. 48.
    Hung PL, Chang WN, Huang LT, et al. A clinical and electrophysiologic survey of childhood Guillian-Barre syndrome. Pediatr Neurol 2004; 30:86–91.PubMedCrossRefGoogle Scholar
  49. 49.
    Marinelli, WA, Leatherman JW. Neuromuscular disorders in the intensive care unit. Crit Care Clin 2002;18:915–929.PubMedCrossRefGoogle Scholar
  50. 50.
    Tekgul, H, Serdaroglu G, Tutuncuoglu S. Outcome of axonal and demyelinating forms of Guillian-Barre syndrome in children. Pediatr Neurol 2003;28:295–299.PubMedCrossRefGoogle Scholar
  51. 51.
    Tan MJ, Chattophadyay AK, Griffiths PD, Baxter PS. Acute central and peripheral demyelination associated with Mycoplasma pneumoniae. Pediatr Neurol 2003;29:239–241.PubMedCrossRefGoogle Scholar
  52. 52.
    Facari M, Lanino E, Dini G, et al. Severe neurologic complications after hematopoietic stem cell transplantation in children. Neurology 2002;59:1895–1904.Google Scholar
  53. 53.
    Colan RV, Snead OC, Oh SJ, Benton JW. Steroid-responsive polyneuro- pathy with subacute onset in childhood. J Pediatr 1980;97:374– 377.PubMedCrossRefGoogle Scholar
  54. 54.
    Oh SJ, Kurokawa K, de Almeida DF, Ryan HF, Claussen GC. Subacute inflammatory demyelinating polyneuropathy. Neurology 2003;61:507– 1512.Google Scholar
  55. 55.
    Chitnis T, Khoury SJ. Immunologic neuromuscular disorders. J Allergy Clin Immunol 2003;111:(Suppl 2):S656–668.Google Scholar
  56. 56.
    Raksadawan N. Childhood onset myasthenia gravis. J Med Assoc Thai 2002;85(Suppl 2):S769–777.PubMedGoogle Scholar
  57. 57.
    Bertorini TE. Perisurgical management of patients with neuromuscular disorders. Neurol Clin North Am 2004;22:293–313.Google Scholar
  58. 58.
    Gozal D. Pulmonary manifestations of neuromuscular disease with special reference to Duchenne muscular dystrophy and spinal muscular atrophy. Pediatr Pulmonol 2000;29:141–150.PubMedCrossRefGoogle Scholar
  59. 59.
    Ioos C, Leclair-Richard D, Mrad S, Barois A, Estournet-Mathiaud B. Respiratory capacity course in patients with infantile spinal muscular atrophy. Chest 2004;126:831–837.PubMedCrossRefGoogle Scholar
  60. 60.
    Prahalad S, Bohnsack JF, Maloney CG, Leslie KO. Fatal acute fibrinous and organizing pneumonia in a child with juvenile dermatomyositis. J Pediatr 2005;146:289–292.PubMedCrossRefGoogle Scholar
  61. 61.
    Campbell C, Sherloc R, Jacob P, Blayney M. Congenital myotonic dystrophy: assisted ventilation duration and outcome. Pediatrics 2004;113:811–816.PubMedCrossRefGoogle Scholar
  62. 62.
    Papazian O, Alfonso I. Adolescents with muscular dystrophies. Adolesc Med 2002;13:511–535.PubMedGoogle Scholar
  63. 63.
    Banwell BJ, Mildner RJ, Hassall AC, Becker LE, Vajsar J, Shemie SD. Muscle weakness in critically ill children. Neurology 2003;61:1779– 1782.PubMedGoogle Scholar
  64. 64.
    Wagner KR. Genetic diseases of muscle. Neurol Clin North Am 2002;20:645–678.Google Scholar
  65. 65.
    Gilchrist JM. Overview of neuromuscular disorders affecting respiratory function. Semin Respir Crit Care Med 2002;23:191– 200.PubMedCrossRefGoogle Scholar
  66. 66.
    Phillips MF, Quinlivan RCM, Edwards RHT, Claverley PMA. Changes in spirometry over time as a prognostic marker in patients with Duchenne muscular dystrophy. Am J Respir Crit Care Med 2001;164:2191– 2194.PubMedGoogle Scholar
  67. 67.
    Hukins CA, Hillman DR. Daytime predictors of sleep hypoventilation in Duchenne muscular dystrophy. Am J Respir Crit Care Med 2001;161:166–170.Google Scholar
  68. 68.
    Moxley RT, Ashwal S, Pandya S, et al. Practice parameter: cortic-osteroid treatment of Duchenne dystrophy. Neurology 2005;64: 13–20.PubMedGoogle Scholar
  69. 69.
    Gosselin LE, McCormick KM. Targeting the immune system to improve ventilatory function in muscular dystrophy. Med Sci Sports Exerc 2004;36:44–51.PubMedCrossRefGoogle Scholar
  70. 70.
    Alman BA. Steroid treatment and the development of scoliosis in males with Duchenne muscular dystrophy. J Bone Joint Surg Am 2004;86:519– 524.PubMedGoogle Scholar
  71. 71.
    Yilmaz O. Prednisolone therapy in Duchenne muscular dystrophy prolongs ambulation and prevents scoliosis. Eur J Neurol 2004;11: 541–544.PubMedCrossRefGoogle Scholar
  72. 72.
    Beenakker EA. Intermittent prednisone therapy in Duchenne muscular dystrophy: a randomized controlled trial. Arch Neurol 2005; 62:128–132.CrossRefGoogle Scholar
  73. 73.
    Kapsa R, Kornberg AJ, Byrne E. Novel therapies for Duchenne muscular dystrophy. Lancet Neurol 2003;2:299--310.CrossRefGoogle Scholar

Copyright information

© Springer-Verlag London 2009

Authors and Affiliations

  • Margaret F. Guill
    • 1
  • Thomas P. Shanley
    • 2
  1. 1.Medical College of Georgia Chief, Section of Pulmonary Medicine MCG Children’s Medical CenterAugustaUSA
  2. 2.Division of Critical Care Medicine C.S. Mott Children’s HospitalUniversity of Michigan Medical Center DirectorAnn ArborUSA

Personalised recommendations